Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

HCQ

Coronavirus: Hydroxychloroquine Administered Early Decreased Mortality Hazard Ratio By 66%, A New Study Finds  
Coronavirus: Hydroxychloroquine Administered Early Decreased Mortality Hazard Ratio By 66%, A New Study Finds  Swarajya StaffJul 3, 2020 08:00 PM +05:30 IST
Covid-19 Research Scandal: Medical Journal Lancet Retracts Study  That Halted  Trials Of Anti-Malarial Drug HCQ
Covid-19 Research Scandal: Medical Journal Lancet Retracts Study That Halted Trials Of Anti-Malarial Drug HCQIANSJun 5, 2020 09:44 AM +05:30 IST
 New ICMR Study: Sustained Intake Of HCQ Prophylaxis And Appropriate PPEs Lowers  Infection Risk For Healthcare Workers
New ICMR Study: Sustained Intake Of HCQ Prophylaxis And Appropriate PPEs Lowers Infection Risk For Healthcare WorkersSwarajya StaffJun 1, 2020 10:42 AM +05:30 IST
Medical Journal  Issues Correction On Study That Led WHO To Pause Trial Of Anti-Malarial Drug HCQ On Covid-19 Patients
Medical Journal Issues Correction On Study That Led WHO To Pause Trial Of Anti-Malarial Drug HCQ On Covid-19 PatientsIANSMay 30, 2020 03:24 PM +05:30 IST
Explained: Should India Continue Testing Anti-Malarial Drug HCQ For Treating COVID-19 After WHO Moratorium?
Explained: Should India Continue Testing Anti-Malarial Drug HCQ For Treating COVID-19 After WHO Moratorium?Swarajya StaffMay 28, 2020 05:46 PM +05:30 IST
Trial Of Anti-Malarial Drug Hydroxychloroquine As Prophylactic Against Covid-19 Begins In UK
Trial Of Anti-Malarial Drug Hydroxychloroquine As Prophylactic Against Covid-19 Begins In UKIANSMay 21, 2020 04:41 PM +05:30 IST
A New Study Unveiled By Prominent French Virologist Claims  HCQ-AZ Combination Removed Novel Coronavirus  In 92 Per Cent Cases
A New Study Unveiled By Prominent French Virologist Claims HCQ-AZ Combination Removed Novel Coronavirus In 92 Per Cent CasesSwarajya StaffApr 11, 2020 01:12 PM +05:30 IST
After Relaxing Export Ban, India To Supply Hydroxychloroquine, Other Medicines To Nepal And Bhutan
After Relaxing Export Ban, India To Supply Hydroxychloroquine, Other Medicines To Nepal And Bhutan Swarajya StaffApr 10, 2020 03:09 PM +05:30 IST
Amid Coronavirus Pandemic, Government Bans Export of Anti-Malarial Drug Hydroxychloroquine
Amid Coronavirus Pandemic, Government Bans Export of Anti-Malarial Drug HydroxychloroquineSwarajya StaffMar 25, 2020 10:15 AM +05:30 IST
IIT Mandi Team Finds  Target Protein For Action Of Antimalarial Drug Against Zika Virus
IIT Mandi Team Finds Target Protein For Action Of Antimalarial Drug Against Zika VirusSwarajya StaffJan 30, 2019 04:04 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype